Neural Stem Cell Treatment for Amyotrophic Lateral Sclerosis (STEMALS)

Abroad (travel likely)RecruitingPHASE2

Conditions

Amyotrophic Lateral Sclerosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Casa Sollievo Della Sofferenza IRCCS, San Giovanni Rotondo, Foggia, Italy
Centro SLA Azienda Ospedaliera Università Maggiore della Carità, Novara, Italy
Contact: Study coordinator (Letizia Mazzini, MD) · ambulatorio.sla@maggioreosp.novara.it · +39 0321 3733962
Azienda Ospedaliera di Padova, Padua, Italy
Contact: Study coordinator (Gianni Sorarù, MD) · cl.neurologica@aopd.veneto.it · +39049-8213645/646
Azienza Ospedaliera Universitaria - Policlinico "P. Giaccone" Università degli Studi di Palermo, Palermo, Italy
Contact: Study coordinator (Vincenzo La Bella, MD) · info@centroslapalermo.it · +39 091 6555158

Study leads

Angelo L Vescovi, PhD
Study Director
Scientific Director Fondazione IRCCS "Casa Sollievo della Sofferenza"

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS

Amyotrophic Lateral Sclerosis (ALS)

Abroad (travel likely)RecruitingPHASE2

Scottsdale, United States · La Jolla, United States

A Clinical Trial to Evaluate NB-4746 in Participants With Amyotrophic Lateral Sclerosis.

Amyotrophic Lateral Sclerosis (ALS)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Concord, Australia · Randwick, Australia

Tofersen in Non-SOD1 ALS

ALS (Amyotrophic Lateral Sclerosis)

Abroad (travel likely)RecruitingPHASE2

Atlanta, United States · Boston, United States

A Study of LTX-002 in Adult Participants With Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis

Abroad (travel likely)RecruitingPHASE1, PHASE2

Lübeck, Germany · Milan, Italy